TerrAscend (TSNDF) Stock Price, News & Analysis

Company Overview

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: $0.49 to $0.55
• 50-Day Range: $0.50 to $0.71
• 52-Week Range: $0.49 to $2.20
• Volume: 157,085 shs
• Average Volume: 335,029 shs
• Market Capitalization: $155.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TSNDF Stock Analysis - Frequently Asked Questions

How have TSNDF shares performed this year?

TerrAscend's stock was trading at $0.65 at the start of the year. Since then, TSNDF stock has decreased by 18.2% and is now trading at $0.5315.
View the best growth stocks for 2025 here.

How do I buy shares of TerrAscend?

Shares of TSNDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 2/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTC
• Sector: Medical
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: OTC:TSNDF
• CUSIP: N/A
• CIK: 1778129
• Web: www.terrascend.com
• Phone: (717) 610-4165
• Fax: N/A
• Employees: 1,165
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-95,540,000.00
• Net Margins: -29.69%
• Pretax Margin: -18.42%
• Return on Equity: -39.82%
• Return on Assets: -13.67%

Debt

• Debt-to-Equity Ratio: 0.92
• Current Ratio: 1.35
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $317.33 million
• Price / Sales: 0.50
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.83 per share
• Price / Book: 0.66

Miscellaneous

• Outstanding Shares: 293,120,000
• Free Float: 199,612,000
• Market Cap: $159.93 million
• Optionable: N/A
• Beta: 1.62